A total of 50.

A total of 50,417 first HSCTs were in 2006, 43 % were allogeneic, 57 % autologous. Most of of autologous HSCTs entered in America and Europe. The most common malignancy in an allogeneic HSCT was acute myeloid leukemia and the most frequent malignant disease was bone marrow failure syndrome , and the most frequent indication … [Read more…]